Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ET140203 |
Trade Name | |
Synonyms | ET 140203|ET-140203 |
Drug Descriptions |
ET140203 are autologous T lymphocytes that have been engineered to express a T-cell receptor mimetic (TCRm) construct that targets an undisclosed tumor-associated antigen, potentially leading to cytotoxic T-cell mediated tumor cell killing (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C175306 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ET140203 | ET140203 | 0 | 2 |